Dialysis Machines Market Segmented By Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables Product with Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease Indication
Industry: Healthcare
Published Date: December-2022
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 280
Report ID: PMRREP32797
Worldwide revenue from the dialysis machines market stands at US$ 18.1 Bn in 2022, with the global market estimated to surge ahead at a CAGR of 2.8% to reach a valuation of US$ 24.5 Bn by the end of 2033.
| Attributes | Key Insights |
|---|---|
|
Dialysis Machines Market Size (2023) |
US$ 18.1 Bn |
|
Projected Market Value (2033) |
US$ 24.5 Bn |
|
Global Market Growth Rate (2023-2033) |
2.8% CAGR |
|
Market Share of Top 5 Countries |
59.6% |
As assessed by Persistence Market Research, hemodialysis devices are expected to hold a market value of US$ 12.8 Bn by 2033. Overall, dialysis machines market sales account for approximately 18.7% revenue share in the global kidney disease market, which was valued at around US$ 96.72 Bn in 2022.
The global market for dialysis machines recorded a historic CAGR of 2.7% in the last 6 years from 2016 to 2022.
The use of membrane technology is expanding quickly. Membranes were initially used extensively to support the progression of research and innovation in theoretical physics and chemistry, as opposed to being used for commercial purposes.
Researchers began designing membrane technologies for human survival because of various technological strengths. Haemodialysis (HD), a form of dialysis where the membrane functions as an artificial kidney, is one of the applications for treating kidney disease. In both acute and chronic illnesses, hemodialysis serves to extend the patient's life instead of to heal them.
Patients who experience a sudden decline in blood quality brought on by the build-up of toxins have been shown to have acute kidney injury (AKI) and acute-on-chronic kidney failure (ACKF).
One of the major health issues facing the diseased population around the world is kidney failure. It refers to the kidneys' inability to carry out their fundamental functions, which include removing waste products from body metabolisms and preserving the body's electrolyte balance.
Common causes include illnesses and injuries that result in sepsis or systemic inflammatory response syndrome. Patients with AKI can receive either continuous renal replacement therapy (CRRT) or intermittent hemodialysis (IHD) as a form of dialysis. Excess water and waste are primarily eliminated during AKI dialysis sessions.
The demand for home dialysis is expanding due to rising levels of income and availability for the middle-income group. From the perspective of commercial and private investors, nephrology is one of the single speciality topics and a desirable sub-segment within the healthcare chain.
By maintaining quality standards, operational efficiency, convenience, and economic advantages to dialysis patients, innovations and competitiveness in this field will ultimately contribute to postpone the mortality of dialysis patients and enhance their quality of life.
The global market is thus likely to show high growth over the coming years at a CAGR of 2.8% and reach a global market size of US$ 24.5 Bn by 2033.
“Automation of Existing Dialysis Machines”
Over time, there have been several advancements made to peritoneal dialysis (PD). Among the many developments are the enrichment of fluid quality, the reliability of catheters and connectors, and understanding of the peritoneal membrane with in mass transfer separation process typical of PD.
Parallel to these successes, PD approaches have also seen notable advancements, largely because of the development of machines and cyclers. Initially, fluid was manually delivered and drained from the peritoneal cavity by gravity into bottles or other containers.
Consequently, the development of automatic or semi-automatic equipment has made it possible to provide a sufficient treatment at night without the involvement of the patient or a caregiver.
With these developments, the issue of therapeutic delivery was resolved, but other issues, such as complications and prescription adherence, could only be addressed using magnetic cards that contained information from various therapies and were brought by the patient to the subsequent regularly scheduled hospital session. Today, the new cycler “HOMECHOICE CLARIA” outfitted with SHARESOURCE software and a bidirectional connection protocol that enables full remote patient management (RPM), and this has solved these constraints.
In patients receiving long-term PD, RPM has shown to have a number of benefits, including a greater overall survival rate, a lower rate of comorbidities, and reduced costs.
“Limitations of Current Dialysis Methods”
Dialysis treatment has come to a crossroads because of a number of problems and bottlenecks, despite being a great option for millions of individuals around the globe and offering a transition to transplantation.
First, CKD as a whole is one of the most expensive non-communicable diseases because dialysis costs only make up a small part of total healthcare spending for a small portion of the general population.
Second, only uremic solute clearance is replaced by dialysis; other kidney processes including hormone generation, blood pressure management, and tubular reabsorption of important substances are not. Moreover, clearance recovery is only limited and only replaces glomerular function; tubular function is not replaced by dialysis.
Third, the results are poor, with survival rates that are lower than those for most cancers or kidney transplants are. Fourth, due to water use, greenhouse gas production, and waste generation, dialysis has a substantial impact on the environment that is around 20 times greater compared to kidney transplantation.
Fifth, dialysis has a significant negative influence on quality of life and is incapable in preventing physically uncomfortable symptoms such itching, cognitive impairment, discomfort or appetite loss, concerns about one's physical appearance, and limitations on social engagement.
The majority of patients receive hemodialysis in-centre, which entails transportation and offers little flexibility in regards to treatment timings and movement. Flexibility is increased with peritoneal dialysis, but long-term use is hampered by the potential loss in peritoneal membrane functionality.
Last but not least, application is intermittent, especially for hemodialysis, with varying intervals between removal procedures, resulting in inherent variations in electrolytes and fluid status, which has an unfavourable prognostic impact.
Why is the U.S. Dialysis Machines Market Booming?
“Growing Burden of Disease and Treatment Availability”
The U.S. accounted for around 87.5% market share in the North America market in 2022. The United States is driving regional market expansion as a result of its sizable diabetic population as well as rising levels of obesity, high blood pressure, as well as other lifestyle problems.
Additionally, with rising healthcare expenditures, as well as the availability of federal reimbursement programs, the demand for dialysis machines is gaining traction in the country. Growing concerns regarding the rising prevalence of chronic kidney disease is further driving the market within the U.S.
Will Germany Be a Lucrative Market for Dialysis Machines Manufacturers?
“Reimbursement Availability and Rising Geriatric Population”
Germany held around 21.8% market share of the Europe market in 2022. The development of the industry at the national level will be aided by favourable reimbursement policies and the presence of major corporations. Germany is one of the nations with a high incidence of renal failure. There are around 80,000 people in the nation who have end-stage renal disease (ESRD). Peritoneal dialysis or hemodialysis are used to treat these patients.
Another important aspect propelling market growth in Europe is the growing elderly population. For instance, according to Eurostat statistics, more than one fifth of the EU's population—20.6%—is over the age of 65 in 2020, and the proportion of people 80 and older is projected to increase from 5.9% to 14.6% by 2100.
How is China Emerging as a Prominent Market for Dialysis Machines?
“Rising Incidence of End-Stage Renal Disease”
China held the largest market share of about 64.6% of the East Asia market in 2022. The number of end stage renal disease patients is on the rise, high blood pressure and diabetes are becoming more common, and there are more dialysis centres opening up across China, all of which are driving the demand for dialysis machines in that country. Due to the risk involved in kidney transplants, customers are increasingly choosing dialysis treatments, which is likely to support market growth during the projection period.
Which Product is Driving Growth of the Global Market?
“Greater Uptake Owed to Ease of Treatment”
Hemodialysis devices segment held around 53.9% share of the global market in 2022. Three times a week, three to five hours per session, hemodialysis can be performed at home, at a hospital, or at a dialysis facility. Arteriovenous (AV) fistulas, the gold standard vascular access utilised to access a person's blood, are used during hemodialysis. Additionally, hemodialysis needs less surgical intervention, leading to a wider product uptake globally.
Which Indication is Largely of Concern for the Manufacturing of Dialysis Machines Globally?
“Long Term Impact of ESRD”
End stage renal disease (ESRD) holds a market share of around 42.2% in 2022. The final stage of chronic (long-term) kidney illness is end-stage kidney disease (ESKD). With end-stage renal disease (ESRD), a patient's renal capacity ceases to function permanently, prompting either a kidney transplant or a continual course of long-term dialysis to maintain the necessary conditions. Beneficiaries' eligibility for Medicare may be determined by their ESRD. Due to the increasing prevalence of ESRD, the category has a greater market share globally.
Which End User Offers the Dialysis Machines Market a Profitable Outlook?
“Large Infrastructure Catering to Equipment Requirements”
Hospitals held a larger share of about 37.0% with a market value of around US$ 6.7 Bn in 2022. Patients undergoing hemodialysis are increasing, as are the number of hospital-based and standalone units. In addition to having specific needs for cleaned water, energy, medicinal gases, and waste disposal, a dialysis unit also provides patient care. Additionally, it calls for providing space for all of the healthcare professionals engaged, providing for emergency procedures, enabling proper hygiene, and maintaining specialist equipment. Thus, dialysis machines in institutional settings like hospitals hold a greater market share.
In order to enhance their respective market shares and customer bases, manufacturers are concentrating on manufacturing dialysis machines, which are affordable. To meet consumer demand, emerging companies and established market leaders are working to develop low cost dialysis machines.
Key instances include:
| Attribute | Details |
|---|---|
|
Forecast Period |
2023-2033 |
|
Historical Data Available for |
2016-2022 |
|
Market Analysis |
USD Million for Value |
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
Product:
Indication:
End User:
Region:
To know more about delivery timeline for this report Contact Sales
The global market is currently valued at around US$ 18.1 Bn in 2022.
Sales of dialysis machines are set to witness a growth at a CAGR of 2.8% and be valued at around US$ 24.5 Bn by 2033.
Demand for dialysis machines increased at a 2.7% CAGR from 2016 to 2022.
The U.S., Germany, U.K., France, and Italy account for most demand for dialysis machines, currently holding around 59.6% market share.
The U.S. accounts for around 87.5% share of the North American market in 2022.
Latin America accounts for around 5.9% share of the global market in 2022.
The China market held a share of about 64.6% in the East Asia market in 2022.
Germany held around 21.8% market share of the Europe market in 2022.
The Brazil market is expected to grow at a 4.1% CAGR during the forecast period.
Indian market is set to expand at a 1.7% CAGR over the forecast period.
